DM5167
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DM5167, covering 2025-08-03 to 2025-08-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of DM5167 in Patients With Advanced Solid Tumors [Phase 1]